Stratagen Quantitative Prostate MRI Platform Pilot Study

Recruiting now · Not applicable

Conditions studied: Prostate Cancer

In brief

The goal of this clinical trial is to assess the safety and feasibility of the Stratagen Quantitative Prostate MRI Platform when used in addition to the standard scans conducted during the existing prostate MRI sessions. * What severe problems, if any, occur because of the use of the Stratagen Quantitative Prostate MRI Platform? * Can the data collected be used to measure quantitative MRI parameters? Participants will: \- Receive up to 15 minutes of additional MRI scan time during the existing prostate MRI imaging session.

Key facts

Study ID
NCT06985238
Run by
Stratagen Bio, Inc.
People needed
75
Starts
2025-09-24
Expected to finish
2026-10-31
Last updated by the study team
2026-03-06

Who can join

Age: 40 and older, up to 90. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.